Effect of Corpulence on pTau217 Measurements in Plasma
Our results show that corpulence, a body mass measure, is associated with plasma biomarker levels. Accounting for corpulence might lead to significant improvements in plasma-based early detection of AD.
Authors
- Martie Marshall
- Rachel Studer (ORCID: https://orcid.org/0000-0002-4321-6210)
- Erin M. Jonaitis (ORCID: https://orcid.org/0009-0004-5091-8255)
- Rachael E. Wilson (ORCID: https://orcid.org/0000-0003-4197-7777)
- Julie Elisabeth Oomens (ORCID: https://orcid.org/0000-0002-5201-8080)
- Nathaniel A. Chin (ORCID: https://orcid.org/0000-0001-8008-9356)
- Monica VandenLangenberg
- Ramiro Eduardo Rea Reyes (ORCID: https://orcid.org/0000-0001-9749-282X)
- Sanjay Asthana (ORCID: https://orcid.org/0000-0002-3998-4479)
- Beckie Jeffers
- Elysse Keske
- Aaron Fredricks
- Cindy Jensen
- Henrik Zetterberg
- Sterling C Johnson
- Rebecca E. Langhough
Institutions
- University of Wisconsin–Madison (US)
- Hong Kong Science and Technology Parks Corporation (HK)
- Sahlgrenska University Hospital (SE)
- UK Dementia Research Institute (GB)
- University of Wisconsin Health (US)
- Wisconsin Division of Public Health (US)
- University College London (GB)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101237
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00